Total tumor volume and growth rate at 3 months on MRI outperform baseline imaging and circulating tumor DNA for predicting survival of patients with metastatic uveal melanoma receiving tebentafusp
Toulsie Ramtohul(Université Paris Sciences et Lettres), Manuel Alves Rodrígues(Inserm), Vincent Servois(Université Paris Sciences et Lettres), Nathalie Cassoux(Institut Curie), Pascale Mariani(Université Paris Sciences et Lettres), Léah Mailly-Giacchetti(Inserm), Shufang Renault(Université Paris Sciences et Lettres), R. Sanchez(Institut Curie), Xavier-Louis Jasawant(Université Paris Sciences et Lettres), Marc-Henri Stern(Inserm), Gaëlle Pierron(Université Paris Sciences et Lettres), Sophie Piperno-Neumann(Université Paris Sciences et Lettres), José Luis Sandoval(Université Paris Sciences et Lettres), Aurore Rampanou(Université Paris Sciences et Lettres)
Cited by 1
Related Papers
Recommendations for Bowel Obstruction With Peritoneal Carcinomatosis
|Journal of Pain and Symptom Management|2014|139
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area
|Breast Cancer Research|2020|125
Multiparametric MRI and Radiomics for the Prediction of HER2-Zero, -Low, and -Positive Breast Cancers
|Radiology|2023|122
Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients
|JNCI Cancer Spectrum|2020|60
Circulating tumor cells and circulating tumor DNA: What surgical oncologists need to know?
|European Journal of Surgical Oncology|2017|45